Status:
COMPLETED
A Randomized, Double-Blind, Controlled Trial to Assess the Efficacy of a Fortetropin Supplement in Improving Symptoms of Osteoarthritis
Lead Sponsor:
MYOS Corp
Collaborating Sponsors:
Citruslabs
Conditions:
Osteoarthritis
Eligibility:
All Genders
50-75 years
Phase:
NA
Brief Summary
This is a hybrid, double-blind, randomized, placebo-controlled clinical trial that will last 12 weeks. Participants will be randomized into either the intervention product or control group and will co...
Eligibility Criteria
Inclusion
- Men and women aged 50-75 years of age
- Self-reporting osteoarthritis-like symptoms, experiencing 3 or more of the following symptoms: joint pain, inflammation, reduced mobility, joint swelling, and stiffness.
- Non-acute osteoarthritis, must have experienced symptoms for longer than 1 year.
- Generally healthy and don't live with any uncontrolled chronic disease
- Able to eat eggs (haven't been medically advised to avoid)
- Willing to stop eating eggs for the 12 week study
Exclusion
- Anyone allergic or intolerant of eggs
- Anyone who has been advised to avoid eggs
- Any pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.
- Anyone with known severe allergic reactions.
- Women who are pregnant, breastfeeding or attempting to become pregnant
- Unwilling to follow the study protocol.
- Subjects currently enrolled in another clinical study
- Subjects having finished another clinical study within the last 4 weeks before inclusion
- Hypersensitivity, allergy, or intolerance against any compound of the test products (e. g. eggs)
- Recent implantation of a cardiac pacemaker or other active implants
- History of or present liver deficiency as defined by Quick \< 70%
- History of hepatitis B, C, HIV
- Subjects who are scheduled to undergo any diagnostic intervention or hospitalization which may cause protocol deviations
- Simultaneous study participation by members of the same household
- Any diet to lose body weight
- Eating disorders or vegan diet
- Present drug abuse or alcoholism
Key Trial Info
Start Date :
June 19 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06021665
Start Date
June 19 2023
End Date
November 1 2023
Last Update
March 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Citruslabs
Santa Monica, California, United States, 90404